Page last updated: 2024-08-22

poloxalene and Ventricular Fibrillation

poloxalene has been researched along with Ventricular Fibrillation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abrahams, SL; Buddemeier, K; Ennis, B; Hubbell, JP; Hursey, TL; Moy, J; Parrillo, JE; Rodriguez, ER; Schaer, GL	1

Other Studies

1 other study(ies) available for poloxalene and Ventricular Fibrillation

Article	Year
Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function. Circulation, 1994, Volume: 90, Issue:6 Topics: Animals; Chemotaxis, Leukocyte; Collateral Circulation; Coronary Circulation; Coronary Disease; Dogs; Gases; Heart; Infusions, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Neutrophils; Poloxalene; Ventricular Fibrillation; Ventricular Function, Left	1994

Article

Year

Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.

Circulation, 1994, Volume: 90, Issue:6

Topics: Animals; Chemotaxis, Leukocyte; Collateral Circulation; Coronary Circulation; Coronary Disease; Dogs; Gases; Heart; Infusions, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Neutrophils; Poloxalene; Ventricular Fibrillation; Ventricular Function, Left

1994